Delivery Order SPE2DB20D2104-SPE2DB24FR39M

Award Date 11/30/23
Potential Completion Date 12/1/23
Potential Value $2.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,551.12 firm fixed-price delivery order is for 4,566,974,492 units of Dexmethylphenidate ER 20 mg capsules, a medication used for treatment of Attention Deficit Hyperactivity Disorder (ADHD). The contract has an ultimate completion date of January 21, 2025. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,171.74 firm fixed price delivery order is for the supply of 4,566,281,681 units of Dexmethylphenidate ER 25 mg capsules, a treatment for ADHD. The contract has an ultimate completion date of October 31, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999...
This federal contract award, valued at $3,061.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 units of dexmethylphenidate extended-release 10 mg capsules, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD). The contract is a Firm Fixed Price Delivery Order with a period of performance through January 21, 2025....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,556,004,424 units of Dexmethylphenidate ER 10 mg Capsules. The firm-fixed-price Delivery Order, valued at $1,008.40, has a completion date of January 21, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $3,898.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,552,082,417 units of Dexmethylphenidate ER 25 mg capsules. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued up to...
This federal contract award is a delivery order (SPE2DB25FZ53B) issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $6,415.50 firm fixed-price contract is for the supply of 4,566,696,959 dexmethylphenidate ER 20 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $2,042.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,557,785,231 units of Dexmethylphenidate ER 25 mg capsules. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,195.14 firm fixed-price delivery order is for the supply of 10 mg Dexmethylphenidate tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $2,033.93, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of dexmethylphenidate ER 10 mg capsules. The contract is a Delivery Order type with a Firm Fixed Price pricing structure, and the ultimate completion date is June 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $1,094.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dexmethylphenidate ER 20 mg capsules and has an ultimate completion date of January 7, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FR39M
    Delivery Order

This federal contract award, valued at $2,522.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract involves the delivery of 4,562,953,314 units of Dexmethylphenidate ER 20 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD).

The contract is a Firm Fixed Price Delivery Order, with a performance period ending on December 1, 2023. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., the parent company, which maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division to provide a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.

Generated 2/27/25, 9:48 AM